To compare functional and oncological outcomes of reproductive organ-sparing cystectomy (ROSC) compared with standard cystectomy (SC) in women undergoing orthotopic bladder substitution (OBS).
Introduction
In women, orthotopic bladder substitution (OBS) has always been less frequently performed because of inferior continence rates and the higher likelihood of needing intermittent selfcatheterization (ISC). The standard surgical approach when performing standard cystectomy (SC) in women is en bloc removal of the bladder, uterus, ovaries and anterior vaginal wall, based on the idea that because of the close proximity of these organs non-removal would increase the risk of local tumour recurrence. In this setting, OBS in women results in continence rates of~50% [1] , and ISC because of incomplete emptying is required in up to 30% of women. Various explanations for this inferior outcome have been suggested, such as a lack of neobladder support after removal of the uterus, with retroflection of the bladder substitute and development of anterior vaginal wall prolapse, as well as the lack of attention given to nerve-sparing (NS) in women. As the neurovascular bundle, which is associated with sexual function and continence, runs along the lateral vaginal wall it can be compromised during cystectomy with resection of the anterior vaginal wall. Organ-sparing surgery, which leaves the reproductive organs (uterus, adnexa) in place, the vaginal wall intact and hence the nerves untouched, is therefore potentially associated with superior functional outcome; however, this is only an option if oncological outcome is not compromised. A recent systematic review highlighted the lack of sufficient evidence on oncological and functional outcomes in women undergoing ROSC or SC [2] . To fill this gap, we evaluated these outcomes in a large consecutive series of women treated with either ROSC or SC at a high-volume tertiary referral centre.
Patients and Methods

Patient Selection
In the period 1995-2016, 121 women were included in this non-randomized single-centre cohort study, which included an ROSC and an SC group. Data were collected prospectively and entered into our institutional database. Of the 121 women, 110 underwent cystectomy and extended pelvic lymph node dissection for malignant disease, and the remaining 11 underwent simple cystectomy for functional reasons. All procedures were performed by two surgeons. Functional outcome was assessed after a follow-up of 12 months, leaving 109 surviving women for evaluation (Fig. 1) . The women were stratified into two groups according to the surgical procedure: ROSC (cystectomy, preservation of the uterus, adnexa and complete vagina, bilateral or unilateral NS; n = 27) and SC (cystectomy, intraoperative hysterectomy or preoperative hysterectomy, with or without partial resection of the anterior vaginal wall, any NS; n = 94). Only 4/121 patients underwent adnexectomy; in 117/ 121 the ovaries were preserved. Only patients reporting complete continence or minimal dropwise incontinence preoperatively were considered for an OBS.
Preoperative staging consisted of a thoracoabdominal CT, a bone scan and transurethral resection/biopsy of the bladder, with biopsies at the level of the bladder neck and bimanual palpation to assess operability and location of the bladder tumour in relation to the vaginal wall. ROSC was performed only if the tumour was located away from the trigone, if the tumour did not appear to have any contact with the vagina on visualized digital palpation during cystoscopy, and if bladder neck biopsies were negative. If the tumour was on the lateral bladder wall, NS was only performed on the non-tumourbearing side.
All patients with malignant disease underwent an extended pelvic lymph node dissection as described previously prior to cystectomy [3] . For ROSC, cystectomy was performed in an antegrade fashion with preservation of the supporting broad and round ligaments. Uterine and ovarian vessels and ovaries were identified and left intact. After division of the superior and inferior vesical arteries and veins along the inferior hypogastric artery, the ureters were divided. The peritoneum was incised at the level of the vesicouterine pouch and the plane between the bladder and anterior vaginal wall was developed in the midline by careful blunt and sharp dissection. The medial pedicle was then dissected and ligated (cauterization was avoided to minimize heat damage to the pelvic plexus) at the level of the anterior vaginal wall, on the tumour-bearing side at the 3 or 9 o'clock position, and on the non-tumour-bearing side at the 1 or 11 o'clock position. The urethra was then transected just below the bladder neck. The OBS was constructed, as previously described, from~54 cm of ileum isolated 25 cm proximal to the ileal cecal valve with an afferent tubular segment (Studer bladder) [4] .
Follow-Up
Patients were seen, according to an institutional follow-up protocol, at 1, 3 and 6 months after surgery, then every 6 months for the first 5 years, and thereafter annually [5] . During these follow-ups, patients underwent vaginal palpation and a lateral standing micturition cystourethrogram (MCUG) in order to exclude prolapse. Follow-up data were prospectively entered into our database according to an ethics committee-approved protocol.
Urinary Continence
Urinary continence was assessed using a previously published standardized institutional questionnaire [6] . For this analysis, continence rates 12 months postoperatively were evaluated. Patients were classified as continent if they required ≤1 safety pad per 24 h. Subpopulation analysis was performed according to attempted NS (none, unilateral or bilateral) in the respective groups (ROSC and SC).
Intermittent Self-Catheterization
Residual urine was assessed either using ultrasonography, provided the bladder substitute was visible, or by in-and-out catheterization. The need for ISC was judged on an individual basis, and was mainly initiated for progressive residual urine and recurrent UTIs (defined as the occurrence of ≥2 positive urine cultures during the same year [7] ). For this analysis, the rate of ISC 12 months postoperatively was used.
Urethral Pressure Profile and Micturition Cystourethrogram
The technique used for urethral pressure profile measurement has been described previously, and was performed according to ICS standards [8] . If available (73/121 patients: (ROSC, n = 16/27; SC, n = 57/94), results of postoperatively performed urethral pressure profile evaluations were assessed and compared between patients in the ROSC and those in the SC group. Lateral MCUGs were performed in patients who underwent urethral pressure profile assessment (73/121) in the standing position by filling the bladder with 300 mL of diluted contrast fluid and asking the patient to strain and to 
Oncological Outcomes
Oncological outcome was assessed in the 110 patients with malignant disease (ROSC, n = 25; SC, n = 85). Assessment was performed on clinical suspicion or according to an institutional standardized protocol based on the pathological TNM stage, consisting of vaginal/rectal palpation, urethral cytology, ureteral cytology and imaging studies. Recurrence was categorized into local or distant. Local recurrence was always proven by biopsy and further categorized into vaginal or urethral recurrence, whereas distant recurrence was mainly diagnosed with imaging with or without successive biopsies. For the purposes of the present study, pelvic lymph node recurrence was not categorized as local recurrence.
Statistical Analysis
Continuous variables are presented as median and ranges, categorical data as counts with percentages. The WilcoxonMann-Whitney test was used for comparison of the two groups. Categorical data were compared using Fisher's exact test or the chi-squared test as appropriate. Statistical significance was set at a two-sided P value <0.05. Oncological outcomes were assessed using the Kaplan-Meier method; curves were compared by logrank test. Statistical analysis was performed using PRISM 6 (GraphPad Software Inc., San Diego, CA, USA).
The study was approved by the local ethics committee (E19-12-13).
Results
Cystectomy was performed for malignant disease in 110/121 patients (urothelial carcinoma n = 94; squamous cell carcinoma, n = 12; adenocarcinoma of the bladder, n = 1; cervical carcinoma, n = 2; urachal carcinoma, n = 1) and for benign conditions in 11/121 patients ( Table 1) . Fifteen patients had received prior therapy (neoadjuvant chemotherapy, n = 11; radiation therapy, n = 4).
In 27/121 patients (22.3%) ROSC was performed; 2/27 (7.4%) for benign disease (low-volume/low-compliance bladder) and 25/27 (92.6%) for malignant disease. SC was performed in 94/ 121 patients (77.7%); 9/94 (9.5%) for benign disease and 85/ 94 (90.5%) for malignant disease. For patients with malignant disease, there was no statistically significant difference in T stage between the SC and the ROSC groups.
The median (range) patient age at the time of surgery was 60.5 (33.9-78.5) years and was similar in the ROSC and SC groups (60.0 and 61.5 years; P = 0.989). The median followup was 3.8 years and was similar in the ROSC group and the SC group (3.2 vs 4.1 years; P = 0.281). Fig. 2] ). This was also true for daytime and nighttime continence rates (87.5% vs 63.53%; P = 0.027, and 87.5% vs 57.65%; P = 0.008 [ Figs 3 and 4] ). In patients who underwent ROSC with attempted bilateral or unilateral NS, 16/18 and 5/6 patients, respectively, were continent during the daytime (P > 0.99). In the SC group, 26/33 (78.8%) with attempted bilateral NS and 26/40 patients (65%) with attempted unilateral NS were continent during the daytime, while 2/12 patients who underwent SC without attempted NS were continent during the daytime (P<0.001).
Nighttime continence was observed in 16/18 patients and 5/6 patients in the ROSC with attempted bilateral and unilateral NS subgroups, respectively (P > 0.99), in 21/33 patients (63.6%) and 24/40 patients (60%) in the SC with bilateral and unilateral NS subgroups, respectively, and in 4/12 patients in the SC with no NS subgroup (P = 0.175).
The rates of de novo ISC were similar in the ROSC and SC groups (12.5% [3/24 patients] vs 12.94% [11/85 patients]; P > 0.99). Of these, one patient experienced a descent of the anterior vaginal wall, and voiding improved after placement of a pessary.
Patients who had undergone ROSC had significantly higher urethral closing pressures at rest compared with patients in the SC group (55.5 vs 44.0 cmH 2 O; P = 0.033). Functional urethral length was similar in both groups (24 vs 26 mm; P = 0.733 [ Fig. 5]) .
Oncological Outcomes
None of the patients had positive surgical margins in the pathology report. In the ROSC group 5/25 patients (21.7%) had died at a median follow-up of 3.2 years, three from metastatic disease and two for other reasons (suicide, n = 1; cardiac infarction, n = 1 [ Table 2 ]). In the SC group, 32/85 patients (37.6%) had died at a median follow-up of 4.1 years, 22 from metastatic disease, three from a secondary malignancy and seven for other reasons (cardiovascular events, n = 5; gastrointestinal bleeding, n = 1; progressive dementia, n = 1).
There were 0/23 isolated local recurrences in the ROSC group compared with 8/85 in the SC group; however, because of the small sample size the difference did not reach significance (0% vs 9.4%; P = 0.126). None of the patients developed ovarian cancer during follow-up. The median calculated overall survival rates for the ROSC and SC groups were 18.9 years and 12.0 years, respectively.
The 5-and 10-year overall survival rates were similar in the ROSC and the SC groups (80.9% and 80.9% vs 64.9% and 55.7%; P = 0.443 [ Fig. 6]) . The 5-and 10-year cancer-specific survival rates were similar in the ROSC and the SC groups (84.2% and 84.2% vs 73.0% and 66.2%; P = 0.431 [ Fig. 7] ).
Discussion
Previously, ROSC was generally not considered an option in women with bladder cancer because of the proximity of the vagina and bladder, but recently there have been some reports on small series of selected patients. There is still a lack of data, however, to form a final consensus either on functional or oncological outcomes, as stated in a recent systematic review on ROSC [2] .
Functional outcomes reported after OBS in women have always been inferior to those in men, with a higher rate of incontinence and more frequent need for ISC owing to incomplete emptying [9] . The reason for this is probably multifactorial. One potential explanation is preservation of the neurovascular bundle affecting both sexual function and continence. In men, the role of NS both in radical prostatectomy and cystectomy has gained increasing acceptance, although its relevance with regard to urinary continence remains a matter of debate [10] [11] [12] [13] . In women, less focus has been placed on NS, although interest is increasing. In women, the autonomic nerve fibres rising from the pelvic plexus run along the rectum and the lateral aspect of the cervix uteri to reach the bladder and the proximal third of the urethra. These nerves can be damaged during pelvic surgery including hysterectomy, and there has been intense discussion on the role of hysterectomy in the development of urinary incontinence [2, 8, 14] . Increasing evidence supports the notion of an association between hysterectomy and incontinence, as well as between the radicality of hysterectomy and urological morbidity. NS during hysterectomy is not only associated with a lower rate of incontinence but also with a more rapid recovery of bladder and anal function [15] [16] [17] [18] . In the same context, hysterectomy and the wide resection of the anterior vaginal wall performed during SC for malignant disease may negatively affect functional outcomes in women. Preservation
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Reproductive organ-sparing cystectomy (n=16) of the genital organs on the other hand alleviates nerve preservation as the plane developed between the vagina and bladder allows the surgeon to leave the tissue along the anterolateral vaginal wall intact. In the present study, with all women reporting continence prior to surgery, continence was significantly more often maintained after ROSC than after SC, both during the day and at night. Attempted bilateral or unilateral NS compared with no attempted NS positively influenced daytime continence in patients who underwent SC, whereas nighttime continence rates did not differ significantly among the three groups because of the similar continence rates between the bilateral and unilateral group. Our day-and nighttime continence rate of 87.5% is in line with the results from other genital organ-sparing case series, with daytime and nighttime continence rates of 64-100% and 50-89%, respectively [2] .
In a previous study, we found that continence was positively associated with a higher urethral closing pressure at rest and organ sparing surgery. These findings are consistent with reports in the gynaecological literature, in which, after radical hysterectomy, continent women had significantly higher urethral closing pressures at rest compared with incontinent women [19] .
Incomplete emptying or 'hypercontinence' is another complication of OBS in women, with reported rates of ISC ranging from 0% to 31% [2] . In the present study, the rate of ISC was the same in both groups and the small number of patients did not allow further analysis of the cause of incomplete emptying. Prolapse of the anterior vaginal wall was not a predominant finding in these patients, in contrast to observations made by others. Oncological outcome, especially local recurrence, is a major concern when considering ROSC, and data are still limited, as noted in a recent systematic review [2] . The results of the present study confirm that in well-selected cases the local recurrence rate is not higher after ROSC than after SC. These findings further support the low local recurrence rates reported in other ROSC series [20] . Although these results are promising, it should be kept in mind that proper patient selection is one of the main keys to success and the results presented should be interpreted with caution given the inherent selection bias of non-randomized studies. Meticulous patient evaluation concerning the location of the tumour in respect to the uterus and vagina is mandatory. In future, better imaging may result in more precise local staging, leading to easier and safer selection of suitable candidates for ROSC. Our 5-year cancer-specific survival rate was similar to that reported by Koie et al. [21] (77% vs 70%). Compared with representative SC series, our reported 5-and 10-year overall survival rates were higher (80.9% and 80.9% vs 55% and 47%) [22] ; this may, at least in part, be explained by the strict selection criteria applied to our ROSC group.
For many surgeons the main indication for ROSC is preservation of sexual function, and greater focus is placed on ROSC in younger patients [14] ; however, even in sexually inactive women, ROSC and NS should be discussed, as continence status is an important factor affecting quality of life.
The present study has some limitations. It is a single-centre report with a limited number of patients, despite being one of the largest available series, and our results may not be translatable to other institutions. Lack of randomization is another issue, but a randomized study would not have been feasible. In addition, data concerning sexual function were missing. There is also a selection bias owing to the stringent selection criteria for ROSC, which may have affected oncological outcomes; however this is inherent to this type of evaluation and could not have been avoided. These limitations notwithstanding, to our knowledge, this is the only cohort study comparing baseline patient characteristics, and functional and oncological results in women undergoing ROSC or SC with OBS performed at the same institution. The results may therefore have better comparability than results in studies on ROSC with OBS only. There are still insufficient data concerning the feasibility and safety of ROSC, as stated in a recent systematic review, but the present study adds to the increasing data supporting the concept of genital organ-sparing. ROSC simplifies NS and this is reflected in the improved functional outcomes in this group and in the correlation of attempted NS and functional outcome overall. In our view, documentation of the degree of NS attempted at the time of surgery and correlation with functional outcome 1 year later is the best evidence attainable. Admittedly, sexual function would further strengthen the evidence. Unfortunately, the availability of these data was limited and thus sexual function was not evaluated in this study. Another issue rarely reported is fertility in young women requiring cystectomy and still contemplating pregnancy. In future, ROSC may allow these young women to achieve this goal.
In conclusion, ROSC with OBS results in higher continence rates compared with SC and OBS in women, without negatively impacting voiding efficiency (ISC) or oncological outcome. In well-selected patients, ROSC should therefore be considered in women undergoing cystectomy and OBS.
